Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease

Circulation

Volumn 95, Issue 3, 1997, Pages 655-661

  Bachmaier, Kurt ^a   Pummerer, Christian ^a,c   Kozieradzki, Ivona ^a   Pfeffer, Klaus ^b   Mak, Tak W ^a   Neu, Nikolaus ^a,c   Penninger, Josef M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

genetics; molecular biology; myocarditis; signal transduction

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXPERIMENTAL MODEL; LEUKOCYTE ACTIVATION; MOUSE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0031054603     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.3.655     Document Type: Article

References (11)

1. Parrillo JE, Aretz HT, Palacios I, Fallon JT, Block PC. The results of transvenous endomyocardial biopsy can frequently be used to diagnose myocardial diseases in patients with idiopathic heart failure: endomyocardial biopsies in 100 consecutive patients revealed a substantial incidence of myocarditis. Circulation. 1984;69:93-101.
2. Martino TA, Liu P, Sole MJ. Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res. 1994;74:182-188.
3. Woodruff JF. Viral myocarditis: a review. Am J Pathol. 1980;101:426-484.
4. Dec GW Jr, Palacios IF, Fallon JT, Aretz HT, Millis J, Lee DC-S, Johnson RA. Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histologic correlates, and clinical outcome. N Engl J Med. 1985;312:885-890.
5. Kasper EK, Agema WR, Hutchins GM, Deckers JW, Hare JM, Baughman KL. The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol. 1994;23:586-590.
6. James TN. Myocarditis and cardiomyopathy. N Engl J Med. 1983;308:39-41.
7. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE, the Myocarditis Treatment Trial Investigators. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med. 1995;333:269-275.
8. McKenna WJ, Davies MJ. Immunosuppression for myocarditis. N Engl J Med. 1995;333:312-313. Editorial comment.
9. Rose NR, Herskowitz A, Neumann DA, Neu N. Autoimmune myocarditis: a paradigm of post-infection autoimmune disease. Immunol Today. 1988;9:117-120.
10. Sinha AA, Lopez MT, McDevitt HO. Autoimmune diseases: the failure of self tolerance. Science. 1990;248:1380-1388.
11. Kaufman DL, Clare Salzler M, Tian J, Forsthuber T, Ting GS, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 1993;366:69-72.